Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4666 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.33 USD | +2.15% | -0.60% | -10.00% | -34.45% | 15.98 M USD | ||
| 4668 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.17 USD | +0.46% | +13.61% | +55.00% | +46.62% | 15.61 M USD | ||
| 4671 |  TPST Tempest Therapeutics, Inc. - Common Stock | 1.03 USD | -0.96% | -5.50% | +13.19% | -56.90% | 15.25 M USD | ||
| 4673 |  BCDA BioCardia, Inc. - Common Stock | 1.02 USD | +0.99% | +8.51% | +13.33% | -12.07% | 15.44 M USD | ||
| 4677 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 7.77 USD | 0.00% | -1.27% | -18.04% | +735.48% | 15.13 M USD | ||
| 4683 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.40 USD | +1.49% | +6.58% | -11.23% | +38.21% | 14.98 M USD | ||
| 4684 |  BIVI BioVie Inc. - Common stock | 1.86 USD | -4.62% | +47.62% | +36.76% | +47.62% | 14.03 M USD | ||
| 4693 |  PASG Passage Bio, Inc. - Common Stock | 4.39 USD | -1.13% | -1.13% | -8.92% | -50.34% | 14.13 M USD | ||
| 4700 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 USD | +27.74% | +70.69% | +23.75% | -21.12% | 17.84 M USD | ||
| 4701 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.17 USD | -0.85% | +9.35% | +10.38% | -1.68% | 13.59 M USD | ||
| 4714 |  GTBP GT Biopharma, Inc. - Common Stock | 0.29 USD | 0.00% | 0.00% | -12.12% | -73.87% | 13.08 M USD | ||
| 4721 |  INAB IN8bio, Inc. - Common Stock | 1.29 USD | +0.78% | +21.70% | +4.88% | -22.75% | 12.72 M USD | ||
| 4725 |  DARE Dare Bioscience, Inc. - Common Stock | 0.81 USD | -1.22% | -8.99% | -36.72% | -50.91% | 12.38 M USD | ||
| 4727 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.37 USD | -2.63% | -19.57% | -40.32% | -67.83% | 12.05 M USD | ||
| 4729 |  PDSB PDS Biotechnology Corporation - Common Stock | 0.21 USD | -4.55% | -4.55% | -69.57% | -83.20% | 11.75 M USD | ||
| 4731 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.89 USD | +2.85% | +1.05% | +1.76% | +2.85% | 12.58 M USD | ||
| 4733 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.98 USD | -4.85% | +3.16% | +3.16% | -47.59% | 11.59 M USD | ||
| 4735 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.35 USD | -10.26% | -16.67% | -12.50% | -63.16% | 10.90 M USD | ||
| 4745 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.65 USD | -0.38% | +3.11% | +6.00% | +26.19% | 11.72 M USD | ||
| 4750 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.58 USD | -1.69% | -3.33% | -72.90% | -81.59% | 11.30 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |